» Authors » Philip C Hill

Philip C Hill

Explore the profile of Philip C Hill including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 192
Citations 4990
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huynh J, Abo Y, Triasih R, Singh V, Pukai G, Masta P, et al.
Int J Infect Dis . 2025 Mar; :107869. PMID: 40049398
Tuberculosis (TB) remains a major global health challenge. Children, adolescents and young mothers are high-risk populations for TB with unique challenges and needs. Children are often misdiagnosed or diagnosed too...
2.
Nijman G, Imran D, Dian S, Ganiem A, Estiasari R, Maharani K, et al.
BMJ Public Health . 2025 Feb; 1(1):e000052. PMID: 40017887
Introduction: Delays in diagnosis and treatment contribute to high mortality of tuberculous meningitis (TBM). We studied TBM patient pathways including delays to diagnosis, and their alignment with available diagnostic services...
3.
Nartey Y, Amo-Antwi K, Osei-Ntiamoah B, Hill P, Dassah E, Asmah R, et al.
Cancer Control . 2025 Feb; 32:10732748251323765. PMID: 40009887
Background: Cervical cancer ranks as the fourth most common cancer among women, with 662,301 new cases and 348,874 deaths reported in 2022. The majority of the disease burden occurs in...
4.
Verrall A, Houghton L, Apriani L, Atmaja H, van Laarhoven A, Ussher J, et al.
Trans R Soc Trop Med Hyg . 2025 Jan; PMID: 39817357
Background: Certain micronutrient levels have been associated with the risk of developing TB disease. We explored the possible association of selected at-risk micronutrient levels with the development of Mycobacterium tuberculosis...
5.
Setiabudiawan T, Apriani L, Verrall A, Utami F, Schneider M, Indrati A, et al.
Nat Commun . 2025 Jan; 16(1):309. PMID: 39747050
Some individuals, even when heavily exposed to an infectious tuberculosis patient, do not develop a specific T-cell response as measured by interferon-gamma release assay (IGRA). This could be explained by...
6.
Lestari B, Afifah N, McAllister S, Miranda A, Herawati E, Hadisoemarto P, et al.
BMJ Glob Health . 2024 Dec; 9(12). PMID: 39622540
Introduction: In high tuberculosis (TB) burden countries, the private sector manages a large proportion of initial visits by presumptive patients with TB. In Indonesia, the second largest contributor of TB...
7.
Nartey Y, Amo-Antwi K, Hill P, Dassah E, Asmah R, Nyarko K, et al.
Cancer Rep (Hoboken) . 2024 Jul; 7(6):e2124. PMID: 39031901
Background: The major burden of cervical cancer occurs in low- and middle-income countries. In Ghana, it is the second most common cancer among women. Infection with high-risk human papilloma virus...
8.
Bates G, Hill P, Koroituku I, Wilson D, Reddy M, Kama M
Trop Med Int Health . 2024 Jun; 29(8):715-722. PMID: 38837811
Objectives: Fiji could be the first country to eliminate tuberculosis. To inform this strategy, we aimed to identify how many GeneXpert® machines are required to enable over 90% of Fijians...
9.
Lestari B, Hadisoemarto P, Afifah N, McAllister S, Fattah D, Salindri A, et al.
PLOS Glob Public Health . 2024 Jun; 4(6):e0003311. PMID: 38833456
In Indonesia, government-owned Community Health Centers (CHCs) spearhead tuberculosis (TB) care at the primary level, but a substantial proportion of individuals with pulmonary TB also seek care from Private Practitioners...
10.
Apriani L, McAllister S, Sharples K, Aini I, Nurhasanah H, Ratnaningsih D, et al.
PLoS One . 2024 Mar; 19(3):e0299874. PMID: 38498488
Background: No gold standard diagnostic test exists for latent tuberculosis infection (LTBI). The intra-dermal tuberculin skin test (TST) has known limitations and Interferon-gamma release assays (IGRA) have been developed as...